19 June, 2020
The COVID-19 outbreak, growing resistance to globalisation, and rising US-China trade tensions—once again—are a perfect recipe for a challenging macroeconomic backdrop. But the news isn’t all bad—according to our Senior Macro Strategist Sue Trinh, the tough operating environment could reveal important growth opportunities for Southeast Asian economies.
Global trade volumes topped out in 2018 amid slowing global growth and ongoing trade tensions between the United States and China. In 2020, the global pandemic has been another headwind for global trade. Nomura’s leading index of Asian exports, which aggregates the region’s exports (excluding Japan) of eight forward-looking components, and typically has a three-month lead, is signaling that aggregate export growth in the region could shrink between 10% to 20% (relative to last year) in the coming months.¹ Further downside risk to global trade comes from the worsening relationship between the United States and China and the potential for a reescalation in trade tensions.
Understandably, this backdrop makes for a difficult environment for Southeast Asian economies—specifically, members of the Association of Southeast Asian Nations (ASEAN), a group of highly trade-dependent economies. That said, how the region weathered challenges in the past two years has given us some confidence in its ability to navigate the current environment.
The ASEAN region has been a big beneficiary of ongoing trade tensions, the global pandemic, and China’s relatively early emergence from the COVID-19 outbreak. The region’s share of global trade has gone from strength to strength since 2000, with trade in electronics and integrated circuits being a major driver. When the U.S.-China trade war started to escalate in early 2018, there were fears that slower global trade growth would negatively impact the trade-dependent region. But as events unfolded, it became clear that China looked increasingly to ASEAN to offset the impact of the trade war—and later, the COVID-19 outbreak—to counter the rise of increasingly stringent U.S. trade policies.
ASEAN’s share of Chinese trade (exports plus imports) overtook that of the United States’ in early 2019. But it didn’t stop there—in early 2020, ASEAN overtook the European Union as China’s largest trading partner and its share of trade with China remains near a record high of around 15%.¹
The ASEAN region has attracted many global companies that are looking to diversify their production in the wake of the U.S.-China trade war, and the COVID-19 outbreak has accelerated that trend. The development is understandable—ASEAN sports many competitive advantages, among them, its member countries’ relatively high rankings in the World Bank’s Ease of Doing Business Index. The ASEAN-6 (namely, Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam) all sit within the top half of global rankings across 10 areas of doing business—starting a business, dealing with construction permits, getting electricity, registering property, getting credit, protecting minority investors, paying taxes, trading across borders, enforcing contracts, and resolving insolvency.2 Other advantages that the region has over its competitors are: relatively lower-wage structures, better productivity, and geographic proximity to China. The fact that the region has a complementary industrial structure to China is also important.²
As China emerges from COVID-19, the gradual recovery in consumer demand in the country is being met by ASEAN; Vietnam, Malaysia, and Thailand have enjoyed particularly strong growth in demand for their goods from China. In our view, sectors that are likely to benefit as the Chinese economy kicks into gear include mining (benefiting major producers from Indonesia and Malaysia), semiconductor and electronics (benefiting Thailand, Malaysia, and Vietnam), and textiles and garment industries (benefiting Vietnam and Thailand).
An acceleration in ASEAN integration in the coming years is likely to make the region even more competitive and resilient to global shocks. This could be achieved by reducing tariffs, improving market access, and increasing the region’s absorptive capacity further. The , a proposed regional free trade agreement that’s currently being negotiated, could go a long way to expand regional connectivity in trade and investment. Proponents of the agreement hope that negotiations can be concluded by the end of the year.³
On balance, even though the leading indicator for Asian export growth is warning of a major slump ahead and geopolitical risks remain elevated, there remain many positive dynamics at play that can serve as mitigants in a challenging environment.
1 Macrobond, as of June 11, 2020.
2 “Doing Business 2020,” The World Bank, October 2019.
3 “RCEP deal expected to be signed late 2020: ASEAN Secretary General,” Xinhuanet.com, March 11, 2020.
Corporate governance in Japan—progress in six key areas
Prominent cases of corporate scandals in Japan in recent years seems to suggest that corporate governance in the country has weakened. The reality, however, is quite different.
Investment implications of the Mainland real-estate debt crisis for Greater Bay Area (GBA)
We discuss the implications of the current real-estate debt crisis for equity investors, as well as various opportunities in the Greater Bay Area.
Asia-Pacific (ex-Japan) equities: Strategic opportunities amid a diverging landscape
Although the divergence in regional performance is expected to continue, we believe the broad Asian equity universe offers attractive opportunities for active managers to find diversification and reasonably valued companies
The information provided on this website is for informational purposes only and is intended solely for use by Singapore residents and is not intended for distribution to, or use by, any person or entity in the United States, or any jurisdiction or country where such distribution or use would be contrary to law or regulation, or which would subject Manulife Investment Management (Singapore) Pte. Ltd. (Company Registration No. 200709952G) and/or its affiliates (collectively hereafter "Manulife") or any of Manulife's products or services to any registration requirement within such jurisdiction or country. Nothing on this website shall be construed as financial advice or an offer, invitation, solicitation or recommendation by or on behalf of Manulife to any person to buy or sell any Fund and is no indication of trading intent in any Fund managed by Manulife. None of the information or analyses presented are intended to form the basis for any investment decision, and no specific recommendations are intended.
Investments in any Fund are not deposits in, guaranteed or insured by Manulife and involve risks. The value of units in any Fund and any income accruing to it may fall or rise. Past performance of the Fund is not necessarily indicative of future performance. The Fund may use or invest in financial derivative instruments. Investors should read the prospectus and seek advice from a financial adviser, before deciding whether to subscribe for or purchase units in any Fund. In the event an investor chooses not to seek advice from a financial adviser, he should consider whether the Fund(s) is/are suitable for him. Copies of the prospectus and the product highlights sheets can be obtained from Manulife or its distributors, for further details (including the risk factors) and charges.
The Manager shall have the absolute discretion to determine whether a distribution is to be made in respect of any Fund as well as the rate and frequency of distributions to be made. The intention of the Manager to make the distribution and the distribution yield for the Fund is not guaranteed, and the Manager may review the distribution policy depending on prevailing market conditions. Distributions may be made out of income, net capital gains and/or capital. Past distribution yields and payments are not necessarily indicative of future distribution yields and payments. Any payment of distributions by the Fund may result in an immediate decrease in the net asset value per unit.
All advertisements or publications provided on this website have not been reviewed by the Monetary Authority of Singapore.
Manulife Investment Management (Singapore) Pte. Ltd. (Company Registration No. 200709952G)